Boston biotech co-founded by Harvard's David Sinclair raises $80 million

Life Biosciences Inc. closed on an $80 million financing that will fund the anti-aging company’s operations into the second ...

Aging may erase epigenetic marks in the brain

Aging may "erase" the epigenetic markers that control gene expression in the brain, and this may snowball to cause unintended ...
Crypto Briefing

David Sinclair: Aging can be reversed, gene therapy is key to rejuvenation, and we may live into the twenty-second century | The Diary of a CEO

Key takeaways. Aging is not an inevitable process and can potentially be reversed. People may live into the twenty-second ...
AOL

As billionaires chase immortality, this startup cofounded by a Harvard genetics professor gets FDA approval for the first partial de-aging human trial

A startup cofounded by a renowned Harvard geneticist has taken a step toward cracking the human body’s biological breakdown by securing FDA approval to test its cutting-edge gene therapy on humans.